Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet regimen for managing HIV infection. This medication combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the virus's ability to copy within the body, considerably lowering the viral load. For many